August 10, 2016 / 11:22 AM / a year ago

BRIEF-Cipher Pharmaceuticals Q2 loss per share c$0.13

1 Min Read

Aug 10 (Reuters) - Cipher Pharmaceuticals Inc

* Cipher pharmaceuticals reports q2 2016 results highlighted by 32% revenue growth and $3.1 million cash from operations

* Cipher pharmaceuticals inc qtrly total revenue of $11.7 million, an increase of 32% from $8.8 million in q2 2015

* Q2 loss per share c$0.13 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below